NanoString Technologies Inc. (NASDAQ:NSTG) fell 3.7% during mid-day trading on Thursday . The stock traded as low as $13.27 and last traded at $13.44, with a volume of 63,913 shares changing hands. The stock had previously closed at $13.96.

Several equities research analysts have recently commented on NSTG shares. Robert W. Baird restated a “buy” rating on shares of NanoString Technologies in a research note on Sunday, May 8th. Morgan Stanley restated a “buy” rating on shares of NanoString Technologies in a research note on Sunday, May 8th. Zacks Investment Research upgraded shares of NanoString Technologies from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Wednesday, May 4th. Finally, BTIG Research restated a “buy” rating on shares of NanoString Technologies in a research note on Sunday, April 3rd. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $19.20.

The stock has a 50-day moving average of $13.36 and a 200 day moving average of $14.26. The company’s market cap is $273.05 million.

NanoString Technologies (NASDAQ:NSTG) last announced its quarterly earnings results on Thursday, May 5th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.69) by $0.05. The business earned $14.70 million during the quarter, compared to analyst estimates of $14.92 million. NanoString Technologies’s revenue was up 26.7% on a year-over-year basis. During the same period last year, the company earned ($0.81) earnings per share. Analysts forecast that NanoString Technologies Inc. will post ($2.42) earnings per share for the current year.

A hedge fund recently raised its stake in NanoString Technologies stock. Morgan Stanley raised its stake in shares of NanoString Technologies Inc. (NASDAQ:NSTG) by 21.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,585,122 shares of the company’s stock after buying an additional 284,101 shares during the period. Morgan Stanley owned 8.13% of NanoString Technologies worth $23,317,000 as of its most recent filing with the SEC.

NanoString Technologies, Inc is engaged in detection, identification and quantification of individual target molecules in a biological sample by attaching a color coded fluorescent reporter to each target molecule of interest. The Company markets its nCounter Analysis System, consisting of instruments and consumables, including its Prosigna Breast Cancer Assay, to academic, government and biopharmaceutical and clinical laboratory customers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.